StockNews.com Initiates Coverage on China Pharma (NYSE:CPHI)

Equities researchers at StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHI) in a research report issued to clients and investors on Sunday. The firm set a “hold” rating on the stock.

China Pharma Trading Down 3.9 %

NYSE:CPHI opened at $0.26 on Friday. China Pharma has a fifty-two week low of $0.13 and a fifty-two week high of $0.41. The company has a quick ratio of 0.26, a current ratio of 0.79 and a debt-to-equity ratio of 0.22. The company has a 50 day moving average price of $0.23 and a 200 day moving average price of $0.22.

China Pharma Company Profile

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.